JOINN adheres to the purpose of "Serve for Drug Innovation,
Focus on Safety Assessments and Monitoring of Drugs Throughout Life Cycles"

MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 28 FEBRUARY 2022

MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 28 FEBRUARY 2022

MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 JANUARY 2022

MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 JANUARY 2022

GRANT OF RESTRICTED A SHARES UNDER THE 2021 RESTRICTED A SHARE INCENTIVE SCHEME

GRANT OF RESTRICTED A SHARES UNDER THE 2021 RESTRICTED A SHARE INCENTIVE SCHEME

POLL RESULTS OF THE FIRST EXTRAORDINARY GENERAL MEETING OF 2022, THE FIRST A SHARE CLASS MEETING FOR 2022 AND THE FIRST H SHARE CLASS MEETING FOR 2022

POLL RESULTS OF THE FIRST EXTRAORDINARY GENERAL MEETING OF 2022, THE FIRST A SHARE CLASS MEETING FOR 2022 AND THE FIRST H SHARE CLASS MEETING FOR 2022

MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 DECEMBER 2021

MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 DECEMBER 2021

Form of Proxy for the First H Share Class Meeting of 2022

Form of Proxy for the First H Share Class Meeting of 2022

Form of Proxy for the First Extraordinary General Meeting of 2022

Form of Proxy for the First Extraordinary General Meeting of 2022

NOTICE OF THE FIRST H SHARE CLASS MEETING OF 2022

NOTICE OF THE FIRST H SHARE CLASS MEETING OF 2022

Leave us a message

Thank you for your attention to JOINN. Please fill in the information below, and we will contact you promptly.

Message

Message

top